Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis

被引:68
|
作者
Kumar, Amit [1 ]
Sharma, Arun [1 ]
Duseja, Ajay [1 ]
Das, Ashim [2 ]
Dhiman, Radha K. [1 ]
Chawla, Yogesh K. [1 ]
Kohli, Krishan K. [3 ]
Bhansali, Anil [4 ]
机构
[1] Postgraduate Inst Med Educ & Res, Dept Hepatol, Sect 12, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Histopathol, Sect 12, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Biochem, Sect 12, Chandigarh 160012, India
[4] Postgrad Inst Med Educ & Res, Dept Endocrinol, Sect 12, Chandigarh 160012, India
关键词
nonalcoholic steatohepatitis (NASH); oxidative stress; cytokines; hepatitis C virus; hepatitis B virus;
D O I
10.1016/j.jceh.2012.10.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Oxidative stress and cytokines play an important role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). We compared the presence of oxidative stress and cytokines in 25 patients with NAFLD with 25 age, sex and BMI-matched patients with chronic viral hepatitis (CVH) and 25 healthy volunteers (HV). Methodology: Oxidative stress was studied biochemically by markers of lipid peroxidation and biochemical assessment of anti-oxidant status and various cytokines were studied by ELISA. Results: Patients with NAFLD had significantly higher levels of malondialdehyde (MDA) (p = 0.000) and conjugated dienes (CD) (p = 0.000) in comparison to HVs. Patients with NAFLD also had significantly higherMDAlevels (p = 0.000) in comparison to CVH patients. Patients with NAFLD had significantly lower GSH levels (p = 0.004) in comparison to HVs. Patients with NAFLD had higher GPx activity (p = 0.028) in comparison to HVs. Catalase activity was significantly decreased in both NAFLD (p = 0.001) and CVH patients (p = 0.000) in comparison to HVs. Patients with NAFLD had significantly higher SOD activity (p = 0.000) in comparison to CVH patients. There was no difference in serum levels of IL-1b and TNF-alpha amongst three groups. Patients with CVH were found to have higher IL-8 serum levels (p = 0.039) in comparison to HVs. CVH patients also had higher TGF-beta levels (p = 0.002) in comparison to both NAFLD patients and HVs. Conclusion: Differences in the markers of oxidative stress and anti-oxidant status between NAFLD, CVH and healthy volunteers suggest presence of higher oxidative stress in patients with NAFLD.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [41] Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: Implications for the influence of fertility on NAFLD
    Kotoh, Kazuhiro
    Nakamuta, Makoto
    Fukushima, Marie
    Morizono, Shusuke
    Enjoji, Munechika
    Nawata, Hajime
    HEPATO-GASTROENTEROLOGY, 2007, 54 (73) : 224 - 228
  • [42] HIGHER URIC ACID LEVELS ARE ASSOCIATED WITH FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Singh, Tavankit
    Parthasarathy, Gopanandan
    Vozzo, Catherine F.
    McCullough, Arthur
    GASTROENTEROLOGY, 2019, 156 (06) : S1236 - S1237
  • [43] Die nichtalkoholische Fettlebererkrankung (NAFLD)Nonalcoholic fatty liver disease (NAFLD)
    S. Zeuzem
    C. Trautwein
    Der Gastroenterologe, 2020, 15 (2): : 77 - 77
  • [44] Conventional inflamation and oxidative stress markers of the nonalcoholic fatty liver disease diagnosed patients
    Muratoglu, S.
    Bilgihan, A.
    Degertekin, B.
    Erkan, G.
    Ercin, U.
    Caliskan, A.
    FEBS JOURNAL, 2015, 282 : 147 - 147
  • [45] Clinical features of chronic hepatitis B patients with lean nonalcoholic fatty liver disease
    Wang, Jian
    Liu, Jiacheng
    Liu, Yilin
    Xue, Ruifei
    Zhan, Jie
    Jiang, Suling
    Wang, Li
    Yan, Xiaomin
    Xiong, Yali
    Xia, Juan
    Yin, Shengxia
    Tong, Xin
    Chen, Yuxin
    Li, Jie
    Huang, Rui
    Wu, Chao
    HEPATOLOGY RESEARCH, 2023, 53 (03) : 184 - 195
  • [46] Noninvasive Diagnostics in Nonalcoholic Fatty Liver Disease (NAFLD)
    Stauber R.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2019, 17 (3) : 75 - 81
  • [47] An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)
    Lomonaco, Romina
    Chen, Janet
    Cusi, Kenneth
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2011, 2 (05) : 211 - 225
  • [48] Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD)
    Itoh, Hiroaki
    Kanayama, Naohiro
    DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD): FROM BIOLOGICAL BASIS TO CLINICAL SIGNIFICANCE, 2018, 1012 : 29 - 39
  • [49] Vitamin E and nonalcoholic fatty liver disease (NAFLD)
    Thakur, Varsha
    Ulatowski, Lynn
    Parker, Robert
    Zhang, Renliang
    Liu, Xiuli
    Manor, Danny
    FASEB JOURNAL, 2013, 27
  • [50] Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)
    Boudaoud, Amel Ait
    Rives-Lange, Claire
    Perregaux, Jean Francois
    Radu, Alina
    Messager-Josipowicz, Diane
    Barsamian, Charles
    Carette, Claire
    Czernichow, Sebastien
    PRESSE MEDICALE, 2019, 48 (12): : 1496 - 1501